AIMS/HYPOTHESIS: The cellular composition of the islet of Langerhans is essential to ensure its physiological function. Morphophysiological islet abnormalities are present in type 2 diabetes but the relationship between fasting plasma glucose (FPG) and islet cell composition, particularly the role of delta cells, is unknown. We explored these questions in pancreases from baboons (Papio hamadryas) with FPG ranging from normal to type 2 diabetic values. METHODS: We measured the volumes of alpha, beta and delta cells and amyloid in pancreatic islets of 40 baboons (Group 1 [G1]: FPG < 4.44 mmol/l [n = 10]; G2: FPG = 4.44-5.26 mmol/l [n = 9]; G3: FPG = 5.27-6.94 mmol/l [n = 9]; G4: FPG > 6.94 mmol/l [n = 12]) and correlated islet composition with metabolic and hormonal variables. We also performed confocal microscopy including TUNEL, caspase-3, and anti-caspase cleavage product of cytokeratin 18 (M30) immunostaining, electron microscopy, and immuno-electron microscopy with anti-somatostatin antibodies in baboon pancreases. RESULTS: Amyloidosis preceded the decrease in beta cell volume. Alpha cell volume increased ∼ 50% in G3 and G4 (p < 0.05), while delta cell volume decreased in these groups by 31% and 39%, respectively (p < 0.05). In G4, glucagon levels were higher, while insulin and HOMA index of beta cell function were lower than in the other groups. Immunostaining of G4 pancreatic sections with TUNEL, caspase-3 and M30 showed apoptosis of beta and delta cells, which was also confirmed by immuno-electron microscopy with anti-somatostatin antibodies. CONCLUSIONS/ INTERPRETATION: In diabetic baboons, changes in islet composition correlate with amyloid deposition, with increased alpha cell and decreased beta and delta cell volume and number due to apoptosis. These data argue for an important role of delta cells in type 2 diabetes.
AIMS/HYPOTHESIS: The cellular composition of the islet of Langerhans is essential to ensure its physiological function. Morphophysiological islet abnormalities are present in type 2 diabetes but the relationship between fasting plasma glucose (FPG) and islet cell composition, particularly the role of delta cells, is unknown. We explored these questions in pancreases from baboons (Papio hamadryas) with FPG ranging from normal to type 2 diabetic values. METHODS: We measured the volumes of alpha, beta and delta cells and amyloid in pancreatic islets of 40 baboons (Group 1 [G1]: FPG < 4.44 mmol/l [n = 10]; G2: FPG = 4.44-5.26 mmol/l [n = 9]; G3: FPG = 5.27-6.94 mmol/l [n = 9]; G4: FPG > 6.94 mmol/l [n = 12]) and correlated islet composition with metabolic and hormonal variables. We also performed confocal microscopy including TUNEL, caspase-3, and anti-caspase cleavage product of cytokeratin 18 (M30) immunostaining, electron microscopy, and immuno-electron microscopy with anti-somatostatin antibodies in baboon pancreases. RESULTS:Amyloidosis preceded the decrease in beta cell volume. Alpha cell volume increased ∼ 50% in G3 and G4 (p < 0.05), while delta cell volume decreased in these groups by 31% and 39%, respectively (p < 0.05). In G4, glucagon levels were higher, while insulin and HOMA index of beta cell function were lower than in the other groups. Immunostaining of G4 pancreatic sections with TUNEL, caspase-3 and M30 showed apoptosis of beta and delta cells, which was also confirmed by immuno-electron microscopy with anti-somatostatin antibodies. CONCLUSIONS/ INTERPRETATION: In diabetic baboons, changes in islet composition correlate with amyloid deposition, with increased alpha cell and decreased beta and delta cell volume and number due to apoptosis. These data argue for an important role of delta cells in type 2 diabetes.
Authors: Subhash Kamath; Alberto O Chavez; Amalia Gastaldelli; Francesca Casiraghi; Glenn A Halff; Gregory A Abrahamian; Alberto M Davalli; Raul A Bastarrachea; Anthony G Comuzzie; Rodolfo Guardado-Mendoza; Lilia M Jimenez-Ceja; Vicki Mattern; Ana Maria Paez; Andrea Ricotti; Mary E Tejero; Paul B Higgins; Iram Pablo Rodriguez-Sanchez; Devjit Tripathy; Ralph A DeFronzo; Edward J Dick; Gary W Cline; Franco Folli Journal: PLoS One Date: 2011-11-18 Impact factor: 3.240
Authors: Alberto O Chavez; Amalia Gastaldelli; Rodolfo Guardado-Mendoza; Juan C Lopez-Alvarenga; M Michelle Leland; M Elizabeth Tejero; GianPio Sorice; Francesca Casiraghi; Alberto Davalli; Raúl A Bastarrachea; Anthony G Comuzzie; Ralph A DeFronzo; Franco Folli Journal: Cardiovasc Diabetol Date: 2009-04-23 Impact factor: 9.951
Authors: R Guardado-Mendoza; L Jimenez-Ceja; A Majluf-Cruz; S Kamath; T V Fiorentino; F Casiraghi; A O C Velazquez; R A DeFronzo; E Dick; A Davalli; F Folli Journal: Int J Obes (Lond) Date: 2012-12-11 Impact factor: 5.551
Authors: Natalia E Schlabritz-Loutsevitch; Anthony G Comuzzie; Michael M Mahaney; Gene B Hubbard; Edward J Dick; Mehmet Kocak; Sonali Gupta; Maira Carrillo; Mauro Schenone; Arnold Postlethwaite; Andrzej Slominski Journal: Comp Med Date: 2016-04 Impact factor: 0.982
Authors: Mary-Elizabeth Patti; Allison B Goldfine; Jiang Hu; Dag Hoem; Anders Molven; Jeffrey Goldsmith; Wayne H Schwesinger; Stefano La Rosa; Franco Folli; Rohit N Kulkarni Journal: Acta Diabetol Date: 2017-05-17 Impact factor: 4.280
Authors: Andrew T Templin; Daniel T Meier; Joshua R Willard; Tami Wolden-Hanson; Kelly Conway; Yin-Guo Lin; Patrick J Gillespie; Krister B Bokvist; Giorgio Attardo; Steven E Kahn; Donalyn Scheuner; Rebecca L Hull Journal: Diabetologia Date: 2018-07-25 Impact factor: 10.122
Authors: Stefan Jacob; Concha F García-Prieto; Rafael Arrojo E Drigo; Xiaofeng Zheng; Masahiro Fukuda; Hoa Tran Thi Nhu; Olga Stelmashenko; Flavia Letícia Martins Peçanha; Rayner Rodriguez-Diaz; Eric Bushong; Thomas Deerinck; Sebastien Phan; Yusuf Ali; Ingo Leibiger; Minni Chua; Thomas Boudier; Sang-Ho Song; Martin Graf; George J Augustine; Mark H Ellisman; Per-Olof Berggren Journal: Nat Commun Date: 2019-08-16 Impact factor: 14.919